Abstract
Myxococcus sp. is an important large genus in the family of myxobacteria because it is considered a prospecting source of secondary metabolites. This study aims to: (i) Identify potential NC01 strain by morphological, biochemical and 16S rDNA gene sequences; (ii) Evaluate antimicrobial activity by agar well-diffusion and microdilution methods; (iii) Survey medium and fermentation conditions that exhibit the best antimicrobial activity and (iv) Determine active fractionation by thin-layer chromatography (TLC) bioautography. The results show that the NC01 strain was designated Myxococcus fulvus. This strain demonstrated inhibition in 9/10 of the strains tested with the most impressive activity being recorded on MSSA, A. niger and Penicillium sp. with a minimum inhibitory concentration of 1 μg/mL however this strain did not show inhibition of E. coli. The survey of fermentation conditions revealed the crude extract exhibited the best antimicrobial activity on medium P at pH 7.2, temperature 37 oC. The two segments No. 2 and No. 3 (Rf = 0.23 and Rf = 0.28) contain compounds that were active on A. niger.
Reference26 articles.
1. Ruan J. [Bergey's Manual of Systematic Bacteriology (second edition) Volume 5 and the study of Actinomycetes systematic in China]. Wei Sheng Wu Xue Bao. 2013 Jun 4;53(6):521-30.
2. Muñoz-Dorado J, Marcos-Torres FJ, García-Bravo E, Moraleda-Muñoz A, Pérez J. Myxobacteria: Moving, Killing, Feeding, and Surviving Together. Front Microbiol. 2016 May 26;7:781. doi: 10.3389/fmicb.2016.00781
3. Zhang X, Yao Q, Cai Z, Xie X, Zhu H. Isolation and identification of myxobacteria from saline-alkaline soils in Xinjiang, China. PLoS One. 2013 Aug 6;8(8):e70466. doi: 10.1371/journal.pone.0070466
4. Saggu SK, Nath A, Kumar S. Myxobacteria: biology and bioactive secondary metabolites. Res Microbiol. 2023 Sep-Oct;174(7):104079. doi: 10.1016/j.resmic.2023.104079
5. Buenconsejo KJP. The Significance of Secondary Metabolism on the Predatory Behavior of Myxococcus fulvus: Drexel University, 2019.